Diferencia entre revisiones de «Template:Pediatric anticonvulsants»
| Línea 5: | Línea 5: | ||
| [[Levetiracetam]] || | | [[Levetiracetam]] || | ||
*60 mg/kg/dose IV/IO | *60 mg/kg/dose IV/IO | ||
*MAX: | *MAX: 4500 mg/dose | ||
|| ≥5 || Any || Most commonly used agent | || ≥5 || Any || Most commonly used agent | ||
|- | |- | ||
| Línea 26: | Línea 26: | ||
*20 mg/kg/dose IV/IO | *20 mg/kg/dose IV/IO | ||
*MAX: 1000 mg/dose | *MAX: 1000 mg/dose | ||
|| ≥20 || <6 months || Respiratory depression, especially in combination with | || ≥20 || <6 months || Respiratory depression, especially in combination with benzodiazepines | ||
|} | |} | ||
Revisión del 18:30 21 nov 2022
Pediatric Anticonvulsants Table
| Drug | Dose | Infusion Rate (Minutes) | Age | Comments/Cautions |
|---|---|---|---|---|
| Levetiracetam |
|
≥5 | Any | Most commonly used agent |
| Fosphenytoin |
|
≥10 | Any | Choose alternate drug if on phenytoin at home; may decrease BP/HR; not for toxin-induced seizures |
| Valproic acid |
|
≥10 | ≥2 years | Caution in patients with liver dysfunction, mitochondrial disease, urea disorder, thrombocytopenia, or unexplained developmental delay |
| Phenytoin |
|
≥20 | Any | Choose alternate drug if on phenytoin at home; may decrease BP/HR; not for toxin-induced seizures |
| Phenobarbital |
|
≥20 | <6 months | Respiratory depression, especially in combination with benzodiazepines |
